After Novartis (NVS) decided to end its RNAi research, Alnylam COO Barry Greene told FierceDrugDelivery that big pharma has "never been able to innovate." Greene attributes the recent sell-off in Alnylam shares to "generally bearish sentiment on Wall Street regarding biotech stocks in particular."
Costco made buying a gold bar as simple as tossing it in a shopping cart. Adam Xi, 33 years old, called five different dealers to get a price he could accept for the gold bar he bought at Costco in October. Costco shoppers are spending as much as $200 million monthly on gold, according to a Wells Fargo estimate.
Super Micro Computer's lack of a preliminary earnings report led to a bloodbath in the sector.
Two more property insurance companies are pulling out of California, leaving more homeowners in the state facing loss of coverage and surging premiums as insurers flee.
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
Super Micro stock fell hard after the data-center computer specialist didn't announce preliminary results for its fiscal Q3.
The high-flying sector caught a bit of gloom at the end of the week due to several discouraging developments.
One of the fastest-growing utility stocks, along with "Wall Street's Greatest Dividend Stock," make for phenomenal buys right now.
Shares of Truth Social's parent rose in another volatile session, extending a roller-coaster stretch of trading for Donald Trump's social-media startup. On Thursday, Trump Media Chief Executive Devin Nunes sent a letter to Nasdaq CEO Adena Friedman asking her to help prevent illegal naked short selling and to make sure trading firms disclose their short positions.
A variety of negative factors, including concern that the company is falling behind in AI, have hurt the stock.
If you are looking to maximize the income your portfolio generates, consider Enterprise Products Partners and Enbridge, but stay away from this midstream giant.
